Geprägs, Alina
Bürgin, David
Fegert, Jörg M.
Brähler, Elmar
Clemens, Vera
Funding for this research was provided by:
Universität Ulm
Article History
Received: 16 December 2023
Accepted: 19 June 2024
First Online: 19 July 2024
Declarations
:
: The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Ethics Committee of the Medical Department of the University of Leipzig (Protocol Number: 298/21-ek; Date of Approval: 12.7.2021). Informed consent was obtained from all individual participants included in the study. In the case of minors, participants gave informed assent with informed consent being provided by their caregivers.
: Not applicable.
: AG, DB, EB and VC declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. JMF has received research funding from EU, BMG, BMBF, BMFSFJ, DFG, G-BA Innovation Fund, State Ministries of Baden-Württemberg and Saarland, Landesstiftung Baden-Württemberg, Porticus Stiftung, Evangelische Landeskirche Baden-Württemberg, travel grants, speakers’ fees, event and training sponsorship from APK, Adenauer and Ebert Foundations, Deutschlandfunk, DFG, DJI, DKSB, Infectopharm, med update, UNICEF, professional associations, universities and federal and state ministries. JMF is consultant for APK, federal and state ministries. JMF has no industry-sponsored lecture series, no shareholdings, no participation in pharmaceutical companies.